Yellow Fever Research Papers

Yellow fever is a viral fever that affects regions of Africa and South America. This virus is passed through mosquito transmission. With advances in research and medicine, scientists have developed a vaccine to combat this virus. These vaccines have been available since the 1970s. Unfortunately like most other vaccines, recent studies have shown some adverse reactions to the vaccine. There is still unknown information about the adverse reactions. These reactions are currently being investigated. Currently, what is known is that reactions are consistent with headaches, fever, and myalgia. The vaccination does contain embryonated eggs and will have an adverse reaction to someone allergic to eggs.
Incidences of the yellow fever virus peaked in the 1980s. Nearly 200,000 incidence of this virus are being reported annually, 90% occurring in Africa. Areas
Africa and South America are still being affected with this virus, especially in populations with a dense mosquito population and/or lack of access to the vaccine. The vaccines developed are not free of negative effects. There are some precautions and certain people may not be able to take the vaccine due to increased risk of developing an adverse reaction. Researchers have concluded that children and the aging population are at greater risk for lethal ramifications of this virus. Scientists have recommended against the administering of this vaccine to children less than one year of age, and for those with a history of thymus disease. There are still opportunities in research with regards to the transmission of the vaccine in breast milk. Until more research is done, scientists have determine that lactating mother retrain from the virus unless at an increased risk of contraction of the virus. Research is still underway as to what causes these serious adverse